相关实验视频
Updated: May 7, 2025
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.3K
免疫系统衍生的miRNAs在心血管疾病中的功能
Albert Sufianov1,2, Murad Agaverdiev3, Andrey Mashkin1,2
1Educational and Scientific Institute of Neurosurgery, Рeoples' Friendship University of Russia (RUDN University), Moscow, Russia.
Non-coding RNA research
|December 31, 2024
概括
免疫系统的微RNAs (miRNAs) 调节心血管功能和炎症. 针对这些"免疫-miRs",特别是T细胞中的免疫-miRs,为心血管疾病 (CVD) 提供了有前途的新治疗策略.
科学领域:
- 心血管免疫学心血管免疫学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 免疫细胞在心血管疾病的发展和进展中发挥着关键作用.
- 来自免疫细胞的微RNAs (miRNAs) 是心血管功能的关键调节者.
研究的目的:
- 审查免疫系统衍生的microRNAs (免疫-miRs) 在心血管疾病中的作用.
- 突出免疫信号通路中的免疫-miRs的调节功能.
- 探索免疫-miRs在心血管疾病治疗中的治疗潜力.
主要方法:
- 关于免疫-miRs和心血管疾病的最近人类和动物研究的审查.
- 对心血管系统内先天性和适应性免疫反应中miRNA参与的分析.
- 专注于调节T细胞功能的miRNAs.
主要成果:
- 免疫-miRs显著影响免疫细胞功能和心血管系统中的信号传递.
- 特定的miRNAs在调节与心血管疾病相关的先天性和适应性免疫力方面发挥了作用.
- 调节T细胞的miRNA被确定为潜在的治疗点.
结论:
- 免疫系统衍生的miRNAs是心血管免疫学的关键调节者.
- 向免疫-miRs,特别是那些影响T细胞的免疫-miRs,为心血管疾病提供了一个新的治疗途径.
- 对免疫-miRs的进一步研究可能会彻底改变心血管疾病管理和治疗策略.
相关概念视频
01:22MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.8K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37